Citizens Financial Group Inc Sage Therapeutics, Inc. Transaction History

Citizens Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$41.13 - $62.45 $10,364 - $15,737	-252 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$25.95 - $43.15 $5,060 - $8,414	195 Added 342.11%	252 $10,000
Q1 2020 May 08, 2020	BUY	$26.15 - $77.24 $1,490 - $4,402	57 New	57 $2,000
Q4 2019 Feb 07, 2020	SELL	$60.18 - $154.77 $1,564 - $4,024	-26 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$157.85 - $183.09 $4,104 - $4,760	26 New	26 $5,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.